相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Inhibitors of the Ubiquitin-Mediated Signaling Pathway Exhibit Broad-Spectrum Antiviral Activities against New World Alphaviruses
Niloufar A. A. Boghdeh et al.
VIRUSES-BASEL (2023)
Characterization of a small molecule inhibitor of disulfide reductases that induces oxidative stress and lethality in lung cancer cells
Fraser D. Johnson et al.
CELL REPORTS (2022)
Thioredoxin Reductase Inhibition for Cancer Therapy
Radosveta Gencheva et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2022)
Comprehensive chemical proteomics analyses reveal that the new TRi-1 and TRi-2 compounds are more specific thioredoxin reductase 1 inhibitors than auranofin
Pierre Sabatier et al.
REDOX BIOLOGY (2021)
Menadione inhibits thioredoxin reductase 1 via arylation at the Sec498 residue and enhances both NADPH oxidation and superoxide production in Sec498 to Cys498 substitution
Shibo Sun et al.
FREE RADICAL BIOLOGY AND MEDICINE (2021)
Single- and Two-Electron Reduction of Nitroaromatic Compounds by Flavoenzymes: Mechanisms and Implications for Cytotoxicity
Narimantas Cenas et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
A Novel Biological Activity of the STAT3 Inhibitor Stattic in Inhibiting Glutathione Reductase and Suppressing the Tumorigenicity of Human Cervical Cancer Cells via a ROS-Dependent Pathway
Yuchen Xia et al.
ONCOTARGETS AND THERAPY (2021)
Identification of Novel Therapeutic Targets for Fibrolamellar Carcinoma Using Patient-Derived Xenografts and Direct-from-Patient Screening
Gadi Lalazar et al.
CANCER DISCOVERY (2021)
5Flavoenzyme-catalyzed single-electron reduction of nitroaromatic antiandrogens: implications for their cytotoxicity
Ausra Nemeikaite-Ceniene et al.
FREE RADICAL RESEARCH (2021)
To inhibit TrxR1 is to inactivate STAT3-Inhibition of TrxR1 enzymatic function by STAT3 small molecule inhibitors
Sander Busker et al.
REDOX BIOLOGY (2020)
Current and Future Prospects of Nitro-compounds as Drugs for Trypanosomiasis and Leishmaniasis
Stephen Patterson et al.
CURRENT MEDICINAL CHEMISTRY (2019)
Piperlongumine increases sensitivity of colorectal cancer cells to radiation: Involvement of ROS production via dual inhibition of glutathione and thioredoxin systems
Hui Wang et al.
CANCER LETTERS (2019)
Nitro-Group-Containing Drugs
Kunal Nepali et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Antiplasmodial Activity of Nitroaromatic Compounds: Correlation with Their Reduction Potential and Inhibitory Action on Plasmodium falciparum Glutathione Reductase
Audrone Maroziene et al.
MOLECULES (2019)
Deregulation of autophagy under hyperglycemic conditions is dependent on increased lysine 63 ubiquitination: a candidate mechanism in the progression of diabetic nephropathy
Paola Pontrelli et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2018)
Irreversible inhibition of cytosolic thioredoxin reductase 1 as a mechanistic basis for anticancer therapy
William C. Stafford et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Oxidative bioactivation of nitrofurantoin in rat liver microsomes
Hui Li et al.
XENOBIOTICA (2017)
N-pentyl-nitrofurantoin induces apoptosis in HL-60 leukemia cell line by upregulating BAX and downregulating BCL-xL gene expression
Jeyce K. F. Andrade et al.
PHARMACOLOGICAL REPORTS (2016)
Covalent Inhibition of Ubc13 Affects Ubiquitin Signaling and Reveals Active Site Elements Important for Targeting
Curtis D. Hodge et al.
ACS CHEMICAL BIOLOGY (2015)
Cytotoxicity of Nitroaromatic Explosives and their Biodegradation Products in Mice Splenocytes: Implications for their Immunotoxicity
Valė Miliukiene et al.
ZEITSCHRIFT FUR NATURFORSCHUNG SECTION C-A JOURNAL OF BIOSCIENCES (2015)
Mechanism of Action of 5-Nitrothiophenes against Mycobacterium tuberculosis
Ruben C. Hartkoorn et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Identification of one-electron reductases that activate both the hypoxia prodrug SN30000 and diagnostic probe EF5
Jingli Wang et al.
BIOCHEMICAL PHARMACOLOGY (2014)
The compound BTB06584 is an IF1-dependent selective inhibitor of the mitochondrial F1Fo-ATPase
Fabrice Ivanes et al.
BRITISH JOURNAL OF PHARMACOLOGY (2014)
Substrate and inhibitor specificities differ between human cytosolic and mitochondrial thioredoxin reductases: Implications for development of specific inhibitors
Oliver Rackham et al.
FREE RADICAL BIOLOGY AND MEDICINE (2011)
The structure of human thioredoxin reductase 1 provides insights into C-terminal rearrangements during catalysis
Karin Fritz-Wolf et al.
JOURNAL OF MOLECULAR BIOLOGY (2007)
Adrenodoxin supports reactions catalyzed by microsomal steroidogenic cytochrome P450s
Tatiana A. Pechurskaya et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Thioredoxin and related molecules - From biology to health and disease
Christopher Horst Lillig et al.
ANTIOXIDANTS & REDOX SIGNALING (2007)
On the potential of thioredoxin reductase inhibitors for cancer therapy
Sabine Urig et al.
SEMINARS IN CANCER BIOLOGY (2006)
Interactions of nitroaromatic compounds with the mammalian selenoprotein thioredoxin reductase and the relation to induction of apoptosis in human cancer cells
N Cenas et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Reactivity of reduced [2Fe-2S] ferredoxins parallels host susceptibility to nitroimidazoles
M Vidakovic et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Reactive oxygen species, antioxidants, and the mammalian thioredoxin system
J Nordberg et al.
FREE RADICAL BIOLOGY AND MEDICINE (2001)
Quantitative structure-activity relationships in enzymatic single-electron reduction of nitroaromatic explosives: implications for their cytotoxicity
N Cenas et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2001)
分享论文
